Can One Health Strategies Be More Effectively Implemented Through Prior Identification Of Public Values?
Funder
National Health and Medical Research Council
Funding Amount
$585,331.00
Summary
Emerging infectious diseases (EIDs) are a significant risk to our region. One Health approaches to EIDs emphasize connections between human,animal and ecological health, enhancing capacity for disease prediction and intervention. This project will examine existing EID legislation,identify social and ethical barriers to effective EID risk governance and create a comprehensive statement of values to ensure the acceptability of One Health approaches to EID control to the Australian community.
Infant Thyroid Hormone Levels And Long-term Child Educational Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$490,495.00
Summary
Adequate levels of newborn thyroid hormones are essential for brain development.Newborn screening for thyroid hormone deficiency ensures early identification, treatment & prevention of severe intellectual disability.But there is clinical uncertainty in mildly abnormal levels.We will assess thyroid hormone levels & subsequent educational outcomes in 1.5M Australian babies.There is potential to identify infants who, without treatment, may suffer longterm disability & lower educational achievement
An Investigation Of The Patient Experience Of Adverse Events.
Funder
National Health and Medical Research Council
Funding Amount
$587,543.00
Summary
Harm during health care (referred to as adverse events) can be serious. Reporting systems have been developed but patients’ experiences of adverse events have remained alarmingly absent. In order to be fully effective policy and services must be designed with these experiences in mind. This study will provide a unique and comprehensive picture of the occurrence of adverse events from the patient's perspective and use this data to enhance policy and service responses.
Addressing Conflicts Of Interest In Public Health And Biomedicine: Enhancing Professional Integrity And Safeguarding The Public’s Health
Funder
National Health and Medical Research Council
Funding Amount
$583,014.00
Summary
It is common for health researchers, clinicians and policymakers to have "conflicts of interest" due, for example, to relationships with private industry. It is widely accepted that conflicts of interest can at times distort research, policymaking and practice, but there is no consensus as to how they should be conceptualised, assessed or managed In this project we will explore the causes and impacts of conflict of interest, and devise a sophisticated framework for managing them.
Characteristics Of Intervention Research That Progresses To 'real-world' Implementation”
Funder
National Health and Medical Research Council
Funding Amount
$555,851.00
Summary
Governments, health agencies and the public are interested in knowing whether publicly funded research “makes a difference” . This project examines 8 years of NHMRC funded research on clinical and community based interventions to change health to better understand understand factors that best promote effective research being later implemented to benefit the community. It will assist planning to facilitate more useful research being funded.
Uptake Of Evidence To Policy: The Indigenous Burden Of Disease Case Study
Funder
National Health and Medical Research Council
Funding Amount
$439,210.00
Summary
Burden of Disease (BOD) methods were designed with the intention of assisting health policy makers in decision making. Using a unit called the Disability Adjusted Life Year, the process measures both death and disability caused by disease or illness, allowing the burden of differing diseases to be compared, and priorities clarified. This research will improve communication between researchers, community and policy makers by showing how the Indigenous BOD study has been used in policy processes.
The Effects Of Different Alcohol Pricing Policies On Alcohol Consumption, Health, Social And Economic Outcomes, And Health Inequality In Australia
Funder
National Health and Medical Research Council
Funding Amount
$276,738.00
Summary
This project will examine the effects, effectiveness and cost-benefits of alcohol pricing policy initiatives in reducing risky drinking, health and social harms and health inequalities among priority populations in Australia. This project will provide key research evidence to cut through current policy debates and will point towards the most effective potential options for alcohol tax reform.
Rates, Patterns And Determinants Of Alcohol’s Harm To Others: A Cross-national Comparative Study
Funder
National Health and Medical Research Council
Funding Amount
$305,856.00
Summary
Alcohol causes harms to drinkers, and others around them, including spouses, children, family, friends, workmates and strangers. Australian and New Zealand work on alcohol’s harm to others is being replicated by the WHO in 7 countries (Chile, Nigeria, Sri Lanka, India, Thailand, Laos and Vietnam). We aim to analyse datasets from nine countries and compare the magnitude and patterning of problems across and within cultures – identifying opportunities for reducing harm from others’ drinking.
A Randomised Trial To Assess The Impact Of A Price Reduction With And Without An In-store Nutrition Education Strategy On Purchasing Of Fruit And Vegetables And Low Joule Drinks And Water In Remote Northern Territory Aboriginal Communities
Funder
National Health and Medical Research Council
Funding Amount
$2,047,955.00
Summary
Low intakes of fruit and vegetables and high soft-drink consumption are key determinants of obesity risk. SHOP@RIC will assess the impact of a 20% price discount with and without an in-store nutrition education strategy on fruit and vegetables, diet soft-drinks, and water purchases in remote Aboriginal community stores. This will provide robust and much needed evidence to support improved nutrition in remote communities and low income populations.
Improving Decisions About The Funding Of High Cost Cancer Medicines In Australia
Funder
National Health and Medical Research Council
Funding Amount
$569,303.00
Summary
In this project, we will address the pressing policy question: How can those funding cancer medicines manage the intensifying economic and ethical challenges that they face? Specifically, we will explore ways of making funding decisions fairer and more legitimate in the eyes of different stakeholders, including patients, the general public, governments and pharmaceutical companies. We will also consider ways in which these guidelines might be generalised to the funding of other medicines.